Formation of Toxic Aβ(1-40) Fibrils on GM1 Ganglioside-Containing Membranes Mimicking Lipid Rafts: Polymorphisms in Aβ(1-40) Fibrils

Journal of Molecular Biology

Volumn 382, Issue 4, 2008, Pages 1066-1074

  Okada, Takuma ^a   Ikeda, Keisuke ^a   Wakabayashi, Masaki ^a   Ogawa, Mariko ^a   Matsuzaki, Katsumi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; amyloid protein; polymorphism; raft like membranes; toxicity

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; GANGLIOSIDE GM1 ANTIBODY; THIOFLAVINE; AMYLOID; AMYLOID BETA PROTEIN; CHOLESTEROL; GANGLIOSIDE GM1; LIPOSOME; PEPTIDE FRAGMENT;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL STRAIN; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOTOXICITY; FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; PROTEIN SECONDARY STRUCTURE; RAT;

AMYLOID; AMYLOID BETA-PROTEIN; ANIMALS; CELL MEMBRANE; CHOLESTEROL; G(M1) GANGLIOSIDE; LIPOSOMES; MEMBRANE MICRODOMAINS; PC12 CELLS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; RATS;

EID: 51249115821     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.07.072     Document Type: Article

References (56)

1. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
2. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
3. Walsh D.M., and Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44 (2004) 181-193
4. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron 6 (1991) 487-498
5. Dahlgren K.N., Manelli A.M., Stine Jr. W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277 (2002) 32046-32053
6. Davis-Salinas J., and Van Nostrand W.E. Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J. Biol. Chem. 270 (1995) 20887-20890
7. Deshpande A., Mina E., Glabe C., and Busciglio J. Different conformations of amyloid β induce neurotoxicity by distinct mechanisms in human cortical neurons. J. Neurosci. 26 (2006) 6011-6018
8. Grace E.A., Rabiner C.A., and Busciglio J. Characterization of neuronal dystrophy induced by fibrillar amyloid β: implications for Alzheimer's disease. Neuroscience 114 (2002) 265-273
9. Jana A., and Pahan K. Fibrillar amyloid-β peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J. Biol. Chem. 279 (2004) 51451-51459
10. Lorenzo A., and Yankner B.A. Amyloid fibril toxicity in Alzheimer's disease and diabetes. Ann. N. Y. Acad. Sci. 777 (1996) 89-95
11. Pillot T., Drouet B., Queille S., Labeur C., Vandekerchkhove J., Rosseneu M., et al. The nonfibrillar amyloid β-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain. J. Neurochem. 73 (1999) 1626-1634
12. Tamagno E., Bardini P., Guglielmotto M., Danni O., and Tabaton M. The various aggregation states of β-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression. Free Radical Biol. Med. 41 (2006) 202-212
13. Tsai J., Grutzendler J., Duff K., and Gan W.B. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat. Neurosci. 7 (2004) 1181-1183
14. Chromy B.A., Nowak R.J., Lambert M.P., Viola K.L., Chang L., Velasco P.T., et al. Self-assembly of Aβ(1-42) into globular neurotoxins. Biochemistry 42 (2003) 12749-12760
15. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M.P., Finch C.E., et al. Alzheimer's disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. USA 100 (2003) 10417-10422
16. Lacor P.N., Buniel M.C., Chang L., Fernandez S.J., Gong Y., Viola K.L., et al. Synaptic targeting by Alzheimer's-related amyloid β oligomers. J. Neurosci. 24 (2004) 10191-10200
17. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., et al. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95 (1998) 6448-6453
18. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., and Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280 (2005) 17294-17300
19. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
20. Hoshi M., Sato M., Matsumoto S., Noguchi A., Yasutake K., Yoshida N., and Sato K. Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β. Proc. Natl. Acad. Sci. USA 100 (2003) 6370-6375
21. Barghorn S., Nimmrich V., Striebinger A., Krantz C., Keller P., Janson B., et al. Globular amyloid β-peptide oligomer-a homogenous and stable neuropathological protein in Alzheimer's disease. J. Neurochem. 95 (2005) 834-847
22. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., et al. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440 (2006) 352-357
23. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
24. Hepler R.W., Grimm K.M., Nahas D.D., Breese R., Dodson E.C., Acton P., et al. Solution state characterization of amyloid β-derived diffusible ligands. Biochemistry 45 (2006) 15157-15167
25. Goldsbury C., Frey P., Olivieri V., Aebi U., and Muller S.A. Multiple assembly pathways underlie amyloid-β fibril polymorphisms. J. Mol. Biol. 352 (2005) 282-298
26. Goldsbury C.S., Wirtz S., Muller S.A., Sunderji S., Wicki P., Aebi U., and Frey P. Studies on the in vitro assembly of Aβ 1-40: implications for the search for Aβ fibril formation inhibitors. J. Struct. Biol. 130 (2000) 217-231
27. Petkova A.T., Leapman R.D., Guo Z., Yau W.M., Mattson M.P., and Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307 (2005) 262-265
28. Yoshiike Y., Akagi T., and Takashima A. Surface structure of amyloid-β fibrils contributes to cytotoxicity. Biochemistry 46 (2007) 9805-9812
29. Matsuzaki K. Physicochemical interactions of amyloid β-peptide with lipid bilayers. Biochim. Biophys. Acta 1768 (2007) 1935-1942
30. Yanagisawa K. Role of gangliosides in Alzheimer's disease. Biochim. Biophys. Acta 1768 (2007) 1943-1951
31. Yanagisawa K., Odaka A., Suzuki N., and Ihara Y. GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1 (1995) 1062-1066
32. Hayashi H., Kimura N., Yamaguchi H., Hasegawa K., Yokoseki T., Shibata M., et al. A seed for Alzheimer amyloid in the brain. J. Neurosci. 24 (2004) 4894-4902
33. Kakio A., Nishimoto S., Yanagisawa K., Kozutsumi Y., and Matsuzaki K. Interactions of amyloid β-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 41 (2002) 7385-7390
34. Wakabayashi M., and Matsuzaki K. Formation of amyloids by Aβ-(1-42) on NGF-differentiated PC12 cells: roles of gangliosides and cholesterol. J. Mol. Biol. 371 (2007) 924-933
35. Wakabayashi M., Okada T., Kozutsumi Y., and Matsuzaki K. GM1 ganglioside-mediated accumulation of amyloid β-protein on cell membranes. Biochem. Biophys. Res. Commun. 328 (2005) 1019-1023
36. Yamamoto N., Fukata Y., Fukata M., and Yanagisawa K. GM1-ganglioside-induced Aβ assembly on synaptic membranes of cultured neurons. Biochim. Biophys. Acta 1768 (2007) 1128-1137
37. Brender J.R., Durr U.H., Heyl D., Budarapu M.B., and Ramamoorthy A. Membrane fragmentation by an amyloidogenic fragment of human islet amyloid polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes. Biochim. Biophys. Acta 1768 (2007) 2026-2029
38. Brender J.R., Lee E.L., Cavitt M.A., Gafni A., Steel D.G., and Ramamoorthy A. Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide. J. Am. Chem. Soc. 130 (2008) 6424-6429
39. Mascioni A., Porcelli F., Ilangovan U., Ramamoorthy A., and Veglia G. Conformational preferences of the amylin nucleation site in SDS micelles: an NMR study. Biopolymers 69 (2003) 29-41
40. Benseny-Cases N., Cocera M., and Cladera J. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation. Biochem. Biophys. Res. Commun. 361 (2007) 916-921
41. Turner D.C., and Brand L. Quantitative estimation of protein binding site polarity. Fluorescence of N-arylaminonaphthalenesulfonates. Biochemistry 7 (1968) 3381-3390
42. Petty S.A., and Decatur S.M. Intersheet rearrangement of polypeptides during nucleation of β-sheet aggregates. Proc. Natl. Acad. Sci. USA 102 (2005) 14272-14277
43. Okada T., Wakabayashi M., Ikeda K., and Matsuzaki K. Formation of toxic fibrils of Alzheimer's amyloid β-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component. J. Mol. Biol. 371 (2007) 481-489
44. Anderson M., Bocharova O.V., Makarava N., Breydo L., Salnikov V.V., and Baskakov I.V. Polymorphism and ultrastructural organization of prion protein amyloid fibrils: an insight from high resolution atomic force microscopy. J. Mol. Biol. 358 (2006) 580-596
45. Heise H., Hoyer W., Becker S., Andronesi O.C., Riedel D., and Baldus M. Molecular-level secondary structure, polymorphism, and dynamics of full-length α-synuclein fibrils studied by solid-state NMR. Proc. Natl. Acad. Sci. USA 102 (2005) 15871-15876
46. Jimenez J.L., Nettleton E.J., Bouchard M., Robinson C.V., Dobson C.M., and Saibil H.R. The protofilament structure of insulin amyloid fibrils. Proc. Natl. Acad. Sci. USA 99 (2002) 9196-9201
47. Goldsbury C.S., Cooper G.J., Goldie K.N., Muller S.A., Saafi E.L., Gruijters W.T., et al. Polymorphic fibrillar assembly of human amylin. J. Struct. Biol. 119 (1997) 17-27
48. Ritter C., Maddelein M.L., Siemer A.B., Luhrs T., Ernst M., Meier B.H., et al. Correlation of structural elements and infectivity of the HET-s prion. Nature 435 (2005) 844-848
49. Yamamoto N., Matsubara E., Maeda S., Minagawa H., Takashima A., Maruyama W., et al. A ganglioside-induced toxic soluble Aβ assembly. Its enhanced formation from Aβ bearing the Arctic mutation. J. Biol. Chem. 282 (2007) 2646-2655
50. Yuan C., and Johnston L.J. Distribution of ganglioside GM1 in l-alpha-dipalmitoylphosphatidylcholine/cholesterol monolayers: a model for lipid rafts. Biophys. J. 79 (2000) 2768-2781
51. Matsuzaki K., Noguch T., Wakabayashi M., Ikeda K., Okada T., Ohashi Y., et al. Inhibitors of amyloid β-protein aggregation mediated by GM1-containing raft-like membranes. Biochim. Biophys. Acta 1768 (2007) 122-130
52. Svennerholm L. Quantitative estimation of sialic acids: II. A colorimetric resorcinol-hydrochloric acid method. Biochim. Biophys. Acta 24 (1957) 604-611
53. Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin. Chem. 19 (1973) 1350-1356
54. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 234 (1959) 466-468
55. LeVine III H. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2 (1993) 404-410
56. Naiki H., and Gejyo F. Kinetic analysis of amyloid fibril formation. Methods Enzymol. 309 (1999) 305-318